Atezolizumab monotherapy vs chemotherapy in untreated locally advanced or metastatic urothelial carcinoma #IMvigor130 : Final overall survival analysis from a randomized, controlled, phase 3 study. #BeyondTheAbstract on UroToday > bit.ly/3WwQ7xV The Lancet Oncology

Leveraging AI biomarkers to navigate the evolving landscape of #BladderCancer treatment Stephen B. Williams, MD, MBA, MS, FACHE UTMBUrology joins Zach Klaassen Georgia Cancer Center to discuss this innovative AI biomarker for #NMIBC > bit.ly/44JLkLj Valar Labs

Erdafitinib or chemotherapy in advanced or metastatic #UrothelialCarcinoma . Arlene Siefker-Radtke MD Anderson Cancer Center joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss the transformative impact of erdafitinib in treating advanced and metastatic urothelial cancer > bit.ly/3v1rqhK

Incorporating PSMA PET into radiotherapy planning: Impact on definitive therapy. Nicholas Nickols dives into the evolution of #ProstateCancer imaging. #WatchNow on UroToday > bit.ly/4bA0tSB PSMA and Beyond Conference UC San Francisco UCLA Prostate Cancer Foundation

The future of #ProstateCancer risk stratification and treatment planning. Eric Kim, MD University of Nevada, Reno and Preston Sprenkle, MD Yale Urology discuss the future of #PCa diagnostics, emphasizing the role of genomic classifiers in refining patient treatment plans > bit.ly/4513xo5

Plant-based diet associated with better QoL in #ProstateCancer survivors. Stacy Loeb, MD NYU Langone Health and Alicia Morgans, MD, MPH Dana-Farber discuss the benefits of a plant-based diet for survivors but also for mitigating risks of other chronic diseases > bit.ly/4akSwyS

Optimizing salvage radiation therapy in #ProstateCancer : New AUA/ASTRO/SUO Guideline. Todd 〽️ Morgan, MD Michigan Urology joins Zach Klaassen Georgia Cancer Center in this discussion of innovative approaches to prostate cancer management on UroToday > bit.ly/4dM3Nez

In case you missed it! Continuing our partnership in education! Check out this Quick Guide to Non-Muscle Invasive #bladdercancer for essential details on diagnosis and treatment options! #NMIBC IBCG Ashish M. Kamat, MD, MBBS

New #BladderCancer treatment: Mechanisms, clinical findings, and implications. Dr. Pat Soon-Shiong ImmunityBio, Inc. & Ashish M. Kamat, MD, MBBS MD Anderson Cancer Center explore the clinical development and approval of #Anktiva and highlight the importance of long-term patient outcomes > bit.ly/3yjE24P

Dive into clinical trial design for #BladderCancer with Rashid K. Sayyid University of Toronto & Zach Klaassen Georgia Cancer Center. They discuss insights from experts on new treatments for advanced urothelial carcinoma, focusing on rational trial designs > bit.ly/3ytQuPG

Revolutionizing #UTUC risk stratification: The promise of urinary and plasma biomarkers. Helen Y. Hougen MD University of Iowa Urology joins Sam S. Chang MD, MBA Vanderbilt Urology to discuss the use of predictive biomarkers and integrating #AI to extract deeper insights > bit.ly/3K4flfq

PEACE V (STORM) trial: Comparing MDT vs elective nodal irradiation for oligorecurrent #ProstateCancer . Thomas Zilli joins Alicia Morgans, MD, MPH to discuss this trial looking to determine the best treatment approach for these patients > bit.ly/3USiaqd

Study reveals that a 6-week multimodal exercise program, before or after prostatectomy, provides significant benefits in #ProstateCancer patients. #Exercise is crucial for better recovery and improved quality of life. #ReadNow on UroToday > bit.ly/45r9ESG Favil Singh

Epidemiology applied to #FocalTherapy in #ProstateCancer : Where do we stand? Kae Jack Tay joins Zach Klaassen to discuss the evolution and current practices in focal therapy for prostate cancer. #WatchNow on UroToday > bit.ly/3K5d6Zl

Association of age with #NMIBC : Unearthing a biological basis for epidemiological disparities? #BeyondTheAbstract with Niyati Lobo and Ashish M. Kamat, MD, MBBS > bit.ly/45FRX21 MD Anderson Cancer Center Royal Free London

Dose-escalation of lutetium PSMA: Final results from a phase I/II trial. Scott Tagawa Weill Cornell Medicine and Zach Klaassen Georgia Cancer Center discuss the safety and efficacy of increasing radioactive doses in a fractionated, dose-dense regimen. #WatchNow > bit.ly/45mTklZ

US clinical practice patterns of intravesical chemotherapy for BCG-unresponsive and BCG-exposed #NMIBC . #BeyondTheAbstract with Mohamad Abou Chakra, Neal D. Shore, MD, FACS, and Michael A. O'Donnell, MD. #ReadNow > bit.ly/4ciuUvX CURC University of Iowa Urology Urology Practice

Bone health management for advanced #ProstateCancer . Fred Saad, MD, FRSC CHUM joins Neal Shore, MD, FACS CURC to present as part of an Independent Medical Education Initiative Supported by Loxo@Lilly Oncology Medical on UroToday > bit.ly/3FYPp2Y

Patient selection for radioligand therapy: Case study discussion. Amir Iravani & Evan Yu, MD Fred Hutchinson Cancer Center join Phillip Koo, MD Banner Health to discuss clinical decisions involving advanced prostate cancer management > bit.ly/3U15lIk

First Prostate Cancer Early Detection Guidelines for Black Men! Enjoyed being a part of this team to help provide clarity for black men with the best available evidence.